Long-term outcomes of more than a decade treating patients with stereotactic body radiation therapy for hepatocellular carcinoma
SBRT resulted in excellent long-term local control rates and absence of severe toxicity in a group of HCC patients. The reported outcomes compare favorably with other local therapies. SBRT should be considered as one of the available local treatment options for HCC.
Authors
- Roeland F. de Wilde (ORCID: https://orcid.org/0009-0003-0444-8697)
- Dave Sprengers (ORCID: https://orcid.org/0000-0003-4280-4210)
- Erik D. van Werkhoven (ORCID: https://orcid.org/0000-0001-7469-7427)
- Wilhelm den Toom
- Imogeen E. Antonisse
- François E.J.A. Willemssen (ORCID: https://orcid.org/0000-0002-8274-3881)
- Ben Heijmen (ORCID: https://orcid.org/0000-0003-1647-0528)
- Eva M Negenman
- Alejandra Méndèz Romero
- Robert J. Porte
Institutions
- Erasmus MC (NL)
- Erasmus MC Cancer Institute (NL)
- Erasmus MC Transplant Institute
Publication Details
- Journal
- Clinical and Translational Radiation Oncology
- Published
- 2024-10-18
- DOI
- https://doi.org/10.1016/j.ctro.2024.100878
- Citations
- 2
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.74